Market Overview:
Histology refers to the study of tissues at a microscopic level whereas cytology is the study of individual cells. Histology and cytology are important tools in cancer diagnosis and are extensively used for screening and identification of malignant and non-malignant lesions. They provide valuable information about the type of cancer, tumor aggressiveness and help design treatment plans.

Market key trends:
Histology and cytology market is witnessing high growth due to growing preference for personalized medicine. Personalized cancer treatment depends on precise analysis of tumor genetics and biomarkers which require advanced diagnostic techniques like histology and cytology. According to a study published in Cell journal, personalized medicine helped achieve complete response rates in 50-60% patients with rare cancers compared to only 10-20% with standard treatments. Further, growing incidence of cancer worldwide is also driving the need for effective cancer screening methods like histology and cytology. As per World Health Organization (WHO), global cancer burden is expected to rise by over 70% in the next two decades leading to over 29Mn new cancer cases by 2040.

Porter's Analysis
Content: Threat of new entrants: The histology and cytology market require high capital investment for equipment and infrastructure development which poses a barrier for new players. Bargaining power of buyers: Buyers have moderate bargaining power due to the presence of several established players offering histology and cytology diagnostic services. Bargaining power of suppliers: Suppliers have low to moderate bargaining power due to availability of substitute raw materials and components. Threat of new substitutes: Threat of substitutes is low as there are limited alternatives available for histology and cytology diagnostics. Competitive rivalry: The market is highly competitive due to presence of global as well as regional players.

SWOT Analysis
Content: Strength: Well established brands and technologies, strong distribution networks. Weakness: High R&D investment and regulatory compliance requirements. Opportunity: Emerging markets growth, increasing adoption of automation and digital pathology. Threats: pricing pressures, unfavorable healthcare reforms.

Key Takeaways
Content: The Global Histology And Cytology Market Demand is expected to witness high growth, exhibiting CAGR of 13% over the forecast period, due to increasing incidence of chronic diseases like cancer. North America dominates the market owing to well developed healthcare infrastructure and higher adoption of advanced diagnostic techniques in the region. The Asia Pacific region is expected to exhibit fastest growth due to rising healthcare expenditures and growing medical tourism in countries like India, China and Malaysia.

Key players operating in the histology and cytology market are Abbott, Hologic Inc., Becton, Southwest Precision Instruments, LLC, F. Hoffmann-La Roche Ltd, Sysmex Corporation, Thermo Fisher Scientific Inc., Danaher, Life Technologies Corporation, Merck KGaA, Koninklijke Philips N.V., Perkin Elmer, and Trivitron Healthcare.

Read More:

https://www.dailyprbulletin.com/histology-and-cytology-market-demand-share-analysis/